|
|
See Category: Diseases of the eye and adnexa
See Header: Exudative age-related macular degeneration, bilateral
ICD-10 (CM) Code and Descriptor
|
H35.3231 |
Exudative age-related macular degeneration, bilateral, with active choroidal neovascularization
Age 14 and up.
|
H353231 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 80.16%
|
9.31%
|
3.63%
|
1.99%
|
1.41%
|
0.99%
|
0.69%
|
0.46%
|
0.37%
|
0.35%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for H35.3231*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
67028
|
INJECTION EYE DRUG |
27,582
|
27,588
|
|
92134
|
CPTRZ OPH DX IMG PST SGM RTA |
22,770
|
22,770
|
|
J0178
|
AFLIBERCEPT INJECTION |
17,981
|
54,251
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
8,031
|
8,040
|
|
C9257
|
BEVACIZUMAB INJECTION |
7,743
|
54,363
|
|
J2778
|
RANIBIZUMAB INJECTION |
2,638
|
18,881
|
|
92014
|
COMPRE OPH EXAM EST PT 1/> |
1,486
|
1,486
|
|
92012
|
INTRM OPH EXAM EST PATIENT |
617
|
617
|
|
92250
|
FUNDUS PHOTOGRAPHY W/I&R |
469
|
469
|
|
92202
|
OPSCPY EXTND ON/MAC DRAW |
458
|
458
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
415
|
547
|
|
J7999
|
COMPOUNDED DRUG, NOC |
357
|
1,454
|
|
J0179
|
INJ, BROLUCIZUMAB-DBLL, 1 MG |
349
|
2,844
|
|
J9035
|
BEVACIZUMAB INJECTION |
269
|
475
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
190
|
190
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
164
|
211
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
142
|
142
|
|
92201
|
OPSCPY EXTND RTA DRAW UNI/BI |
122
|
122
|
|
92235
|
FLUORESCEIN ANGRPH MLTIFRAME |
103
|
103
|
|
97535
|
SELF CARE MNGMENT TRAINING |
97
|
272
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
H35.3231 related to the following DRG Codes:
124-125
|
